1147 - Implantation of fiducial markers into the prostate gland or prostate surgical bed for external beam radiotherapy

Page last updated: 13 July 2016

Application Detail



Description of Medical Service

Implantation of radio-opaque fiducial markers into the prostate gland or prostate surgical bed to assist in the delivery of external-beam radiotherapy. Fiducial markers serve as fiducial reference points during radiotherapy in patients with prostate cancer precisely identify the location of the cancer and deliver accurately guided radiation therapy.

Description of Medical Condition

Prostate cancer is the most common cancer in men. Just over 16,000 cases of prostate cancer (nearly 30% of male cancers) are diagnosed each year in Australia and it is responsible for approximately 3,000 deaths annually. Prostate cancer tends to develop in men over the age of fifty. Patients with localised prostate cancer may be treated with radical prostatectomy or radical radiotherapy.

Reason for Application


Medical Service Type


Previous Application Number

Not Applicable

Associated Documentation

Application Form


PICO Confirmation

Release date: 25 July 2011 to 18 August 2011
Consultation Decision Analytic Protocol (DAP) (PDF 378 KB)
Consultation Decision Analytic Protocol (DAP) (Word 283 KB)

14 – 15 September 2011
Final Decision Analytic Protocol (DAP) (PDF 368 KB)
Final Decision Analytic Protocol (DAP) (Word 351 KB)

Assessment Report

Contracted Assessment Report (PDF 1079 KB)
Contracted Assessment Report (Word 1301 KB)

Public Summary Document

Public Summary Document - August 2013 (PDF 172 KB)
Public Summary Document - August 2013 (Word 90 KB)

Meetings for this Application


7 July 2010


13 - 14 June 2013


1 August 2013